Cargando…
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Diabetes Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695716/ http://dx.doi.org/10.4093/dmj.2023.0328 |
| _version_ | 1785153622953164800 |
|---|---|
| author | Lee, Da Young |
| author_facet | Lee, Da Young |
| author_sort | Lee, Da Young |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10695716 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Korean Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106957162023-12-05 Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81) Lee, Da Young Diabetes Metab J Letter Korean Diabetes Association 2023-11 2023-11-24 /pmc/articles/PMC10695716/ http://dx.doi.org/10.4093/dmj.2023.0328 Text en Copyright © 2023 Korean Diabetes Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Lee, Da Young Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81) |
| title | Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81) |
| title_full | Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81) |
| title_fullStr | Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81) |
| title_full_unstemmed | Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81) |
| title_short | Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81) |
| title_sort | glimepiride compared to liraglutide increases plasma levels of mir-206, mir-182-5p, and mir-766-3p in type 2 diabetes mellitus: a randomized controlled trial (diabetes metab j 2023;47:668-81) |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695716/ http://dx.doi.org/10.4093/dmj.2023.0328 |
| work_keys_str_mv | AT leedayoung glimepiridecomparedtoliraglutideincreasesplasmalevelsofmir206mir1825pandmir7663pintype2diabetesmellitusarandomizedcontrolledtrialdiabetesmetabj20234766881 |